BIOC - .82 Pre-market now at 1.04/1.05 Biocept Announces Clinical Validation and Commercial Launch of its Target Selector™ Multi-Gene Liquid Biopsy Panel for Lung Cancer https://www.tradescores.com/StockReport/bioc